Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial

Clinical trial NCT02699645 · COMPLETED

Trial details

NCT number: NCT02699645
Sponsor: The George Institute
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Intracerebral Haemorrhage (ICH)Hypertension

Start date: 2017-09-28
Primary completion: 2025-08-27
Enrollment: 1671

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.